nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropinirole—DRD2—nicotine dependence	0.615	1	CbGaD
Ropinirole—Terminal insomnia—Varenicline—nicotine dependence	0.00912	0.0397	CcSEcCtD
Ropinirole—Gallbladder disorder—Varenicline—nicotine dependence	0.00697	0.0303	CcSEcCtD
Ropinirole—Blindness transient—Varenicline—nicotine dependence	0.00626	0.0272	CcSEcCtD
Ropinirole—Somnambulism—Varenicline—nicotine dependence	0.0057	0.0248	CcSEcCtD
Ropinirole—Pleurisy—Varenicline—nicotine dependence	0.00468	0.0204	CcSEcCtD
Ropinirole—Joint stiffness—Varenicline—nicotine dependence	0.00379	0.0165	CcSEcCtD
Ropinirole—Sensory disturbance—Varenicline—nicotine dependence	0.00369	0.016	CcSEcCtD
Ropinirole—Peripheral ischaemia—Varenicline—nicotine dependence	0.00313	0.0136	CcSEcCtD
Ropinirole—Respiratory tract congestion—Varenicline—nicotine dependence	0.00313	0.0136	CcSEcCtD
Ropinirole—Varicose vein—Varenicline—nicotine dependence	0.00307	0.0134	CcSEcCtD
Ropinirole—Coronary artery disease—Varenicline—nicotine dependence	0.00289	0.0126	CcSEcCtD
Ropinirole—Hoarseness—Varenicline—nicotine dependence	0.0026	0.0113	CcSEcCtD
Ropinirole—Depressed mood—Varenicline—nicotine dependence	0.00256	0.0111	CcSEcCtD
Ropinirole—Pancreatitis acute—Varenicline—nicotine dependence	0.00248	0.0108	CcSEcCtD
Ropinirole—Myositis—Varenicline—nicotine dependence	0.00233	0.0101	CcSEcCtD
Ropinirole—Sinus congestion—Varenicline—nicotine dependence	0.0023	0.01	CcSEcCtD
Ropinirole—Transient ischaemic attack—Varenicline—nicotine dependence	0.00227	0.00986	CcSEcCtD
Ropinirole—Night sweats—Varenicline—nicotine dependence	0.00212	0.00922	CcSEcCtD
Ropinirole—Balance disorder—Varenicline—nicotine dependence	0.00209	0.0091	CcSEcCtD
Ropinirole—Urine abnormality—Varenicline—nicotine dependence	0.00207	0.00899	CcSEcCtD
Ropinirole—Osteoporosis—Varenicline—nicotine dependence	0.00204	0.00888	CcSEcCtD
Ropinirole—Suicide attempt—Varenicline—nicotine dependence	0.00202	0.00877	CcSEcCtD
Ropinirole—Gastric ulcer—Varenicline—nicotine dependence	0.00197	0.00856	CcSEcCtD
Ropinirole—Urine analysis abnormal—Varenicline—nicotine dependence	0.00194	0.00846	CcSEcCtD
Ropinirole—Libido increased—Varenicline—nicotine dependence	0.00188	0.00818	CcSEcCtD
Ropinirole—Toothache—Varenicline—nicotine dependence	0.00188	0.00818	CcSEcCtD
Ropinirole—Psoriasis—Varenicline—nicotine dependence	0.00182	0.00792	CcSEcCtD
Ropinirole—DRD4—brain—nicotine dependence	0.00179	0.0702	CbGeAlD
Ropinirole—Parosmia—Varenicline—nicotine dependence	0.00176	0.00767	CcSEcCtD
Ropinirole—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00175	0.00759	CcSEcCtD
Ropinirole—Upset stomach—Varenicline—nicotine dependence	0.00175	0.00759	CcSEcCtD
Ropinirole—Pharyngolaryngeal pain—Varenicline—nicotine dependence	0.00169	0.00737	CcSEcCtD
Ropinirole—Menstrual disorder—Varenicline—nicotine dependence	0.00168	0.0073	CcSEcCtD
Ropinirole—Paranoia—Varenicline—nicotine dependence	0.00168	0.0073	CcSEcCtD
Ropinirole—Laryngeal pain—Varenicline—nicotine dependence	0.00168	0.0073	CcSEcCtD
Ropinirole—Intestinal obstruction—Varenicline—nicotine dependence	0.00168	0.0073	CcSEcCtD
Ropinirole—Haematemesis—Varenicline—nicotine dependence	0.00165	0.00716	CcSEcCtD
Ropinirole—Thrombosis—Varenicline—nicotine dependence	0.00162	0.00703	CcSEcCtD
Ropinirole—Delusion—Varenicline—nicotine dependence	0.00162	0.00703	CcSEcCtD
Ropinirole—Mania—Varenicline—nicotine dependence	0.00157	0.00684	CcSEcCtD
Ropinirole—Menorrhagia—Varenicline—nicotine dependence	0.00155	0.00672	CcSEcCtD
Ropinirole—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00152	0.00661	CcSEcCtD
Ropinirole—Scotoma—Varenicline—nicotine dependence	0.00151	0.00655	CcSEcCtD
Ropinirole—HTR1B—cardiovascular system—nicotine dependence	0.00149	0.0584	CbGeAlD
Ropinirole—Fungal infection—Varenicline—nicotine dependence	0.00148	0.00644	CcSEcCtD
Ropinirole—Gingivitis—Varenicline—nicotine dependence	0.00146	0.00634	CcSEcCtD
Ropinirole—HTR1D—cardiovascular system—nicotine dependence	0.00144	0.0565	CbGeAlD
Ropinirole—DRD1—midbrain—nicotine dependence	0.00144	0.0562	CbGeAlD
Ropinirole—Nephrolithiasis—Varenicline—nicotine dependence	0.00142	0.00619	CcSEcCtD
Ropinirole—Glycosuria—Varenicline—nicotine dependence	0.00141	0.00614	CcSEcCtD
Ropinirole—Rhinorrhoea—Varenicline—nicotine dependence	0.00141	0.00614	CcSEcCtD
Ropinirole—Dysphonia—Varenicline—nicotine dependence	0.00139	0.00605	CcSEcCtD
Ropinirole—Endocrine disorder—Varenicline—nicotine dependence	0.00138	0.006	CcSEcCtD
Ropinirole—Acne—Varenicline—nicotine dependence	0.00136	0.00591	CcSEcCtD
Ropinirole—HTR2B—cardiovascular system—nicotine dependence	0.00134	0.0526	CbGeAlD
Ropinirole—Eye irritation—Varenicline—nicotine dependence	0.00134	0.00583	CcSEcCtD
Ropinirole—Disturbance in attention—Varenicline—nicotine dependence	0.00132	0.00574	CcSEcCtD
Ropinirole—Aggression—Varenicline—nicotine dependence	0.0013	0.00566	CcSEcCtD
Ropinirole—Chest discomfort—Varenicline—nicotine dependence	0.00129	0.00562	CcSEcCtD
Ropinirole—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00127	0.00551	CcSEcCtD
Ropinirole—Viral infection—Varenicline—nicotine dependence	0.00127	0.00551	CcSEcCtD
Ropinirole—DRD3—brain—nicotine dependence	0.00126	0.0494	CbGeAlD
Ropinirole—Thinking abnormal—Varenicline—nicotine dependence	0.00125	0.00543	CcSEcCtD
Ropinirole—Nocturia—Varenicline—nicotine dependence	0.00123	0.00536	CcSEcCtD
Ropinirole—Leukocytosis—Varenicline—nicotine dependence	0.00122	0.00529	CcSEcCtD
Ropinirole—HTR1A—cardiovascular system—nicotine dependence	0.0012	0.0471	CbGeAlD
Ropinirole—DRD5—brain—nicotine dependence	0.00118	0.0463	CbGeAlD
Ropinirole—Coordination abnormal—Varenicline—nicotine dependence	0.00116	0.00507	CcSEcCtD
Ropinirole—HTR1B—midbrain—nicotine dependence	0.00116	0.0456	CbGeAlD
Ropinirole—Blood pressure increased—Varenicline—nicotine dependence	0.00114	0.00498	CcSEcCtD
Ropinirole—Pulmonary embolism—Varenicline—nicotine dependence	0.00114	0.00498	CcSEcCtD
Ropinirole—Abnormal dreams—Varenicline—nicotine dependence	0.00113	0.00492	CcSEcCtD
Ropinirole—HTR1D—midbrain—nicotine dependence	0.00113	0.0441	CbGeAlD
Ropinirole—Eructation—Varenicline—nicotine dependence	0.00112	0.00489	CcSEcCtD
Ropinirole—Hyperkalaemia—Varenicline—nicotine dependence	0.00112	0.00489	CcSEcCtD
Ropinirole—HTR2C—midbrain—nicotine dependence	0.00112	0.0437	CbGeAlD
Ropinirole—Influenza like illness—Varenicline—nicotine dependence	0.00111	0.00483	CcSEcCtD
Ropinirole—Salivary hypersecretion—Varenicline—nicotine dependence	0.00111	0.00483	CcSEcCtD
Ropinirole—Nightmare—Varenicline—nicotine dependence	0.0011	0.0048	CcSEcCtD
Ropinirole—Photophobia—Varenicline—nicotine dependence	0.00107	0.00467	CcSEcCtD
Ropinirole—Dry eye—Varenicline—nicotine dependence	0.00106	0.0046	CcSEcCtD
Ropinirole—Oesophagitis—Varenicline—nicotine dependence	0.00105	0.00455	CcSEcCtD
Ropinirole—Mouth ulceration—Varenicline—nicotine dependence	0.00103	0.0045	CcSEcCtD
Ropinirole—Urine output increased—Varenicline—nicotine dependence	0.00103	0.0045	CcSEcCtD
Ropinirole—Hypertonia—Varenicline—nicotine dependence	0.001	0.00436	CcSEcCtD
Ropinirole—Mental disability—Varenicline—nicotine dependence	0.000992	0.00432	CcSEcCtD
Ropinirole—Euphoric mood—Varenicline—nicotine dependence	0.000983	0.00427	CcSEcCtD
Ropinirole—Lymphadenopathy—Varenicline—nicotine dependence	0.000973	0.00423	CcSEcCtD
Ropinirole—Sleep disorder—Varenicline—nicotine dependence	0.000959	0.00417	CcSEcCtD
Ropinirole—Diabetes mellitus—Varenicline—nicotine dependence	0.000954	0.00415	CcSEcCtD
Ropinirole—Polyuria—Varenicline—nicotine dependence	0.000945	0.00411	CcSEcCtD
Ropinirole—HTR1A—midbrain—nicotine dependence	0.00094	0.0368	CbGeAlD
Ropinirole—Deafness—Varenicline—nicotine dependence	0.000928	0.00404	CcSEcCtD
Ropinirole—Disorientation—Varenicline—nicotine dependence	0.000928	0.00404	CcSEcCtD
Ropinirole—Eczema—Varenicline—nicotine dependence	0.000924	0.00402	CcSEcCtD
Ropinirole—Eye pain—Varenicline—nicotine dependence	0.00092	0.004	CcSEcCtD
Ropinirole—DRD1—brain—nicotine dependence	0.000903	0.0353	CbGeAlD
Ropinirole—Renal failure acute—Varenicline—nicotine dependence	0.000899	0.00391	CcSEcCtD
Ropinirole—Libido decreased—Varenicline—nicotine dependence	0.000895	0.00389	CcSEcCtD
Ropinirole—Hot flush—Varenicline—nicotine dependence	0.000887	0.00386	CcSEcCtD
Ropinirole—Increased appetite—Varenicline—nicotine dependence	0.000884	0.00384	CcSEcCtD
Ropinirole—Amnesia—Varenicline—nicotine dependence	0.000884	0.00384	CcSEcCtD
Ropinirole—Menopausal symptoms—Varenicline—nicotine dependence	0.00088	0.00383	CcSEcCtD
Ropinirole—Visual disturbance—Varenicline—nicotine dependence	0.000876	0.00381	CcSEcCtD
Ropinirole—Atrial fibrillation—Varenicline—nicotine dependence	0.000876	0.00381	CcSEcCtD
Ropinirole—Thirst—Varenicline—nicotine dependence	0.000872	0.00379	CcSEcCtD
Ropinirole—Arthritis—Varenicline—nicotine dependence	0.000854	0.00372	CcSEcCtD
Ropinirole—Hypoglycaemia—Varenicline—nicotine dependence	0.000851	0.0037	CcSEcCtD
Ropinirole—DRD2—midbrain—nicotine dependence	0.000849	0.0332	CbGeAlD
Ropinirole—Lethargy—Varenicline—nicotine dependence	0.000847	0.00369	CcSEcCtD
Ropinirole—Osteoarthritis—Varenicline—nicotine dependence	0.00083	0.00361	CcSEcCtD
Ropinirole—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00083	0.00361	CcSEcCtD
Ropinirole—ADRA2C—midbrain—nicotine dependence	0.000825	0.0323	CbGeAlD
Ropinirole—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.000824	0.00358	CcSEcCtD
Ropinirole—Migraine—Varenicline—nicotine dependence	0.000817	0.00355	CcSEcCtD
Ropinirole—Affect lability—Varenicline—nicotine dependence	0.000817	0.00355	CcSEcCtD
Ropinirole—Psychotic disorder—Varenicline—nicotine dependence	0.000811	0.00353	CcSEcCtD
Ropinirole—Irritability—Varenicline—nicotine dependence	0.000792	0.00345	CcSEcCtD
Ropinirole—Urinary retention—Varenicline—nicotine dependence	0.000789	0.00343	CcSEcCtD
Ropinirole—Mood swings—Varenicline—nicotine dependence	0.000786	0.00342	CcSEcCtD
Ropinirole—Dry skin—Varenicline—nicotine dependence	0.000761	0.00331	CcSEcCtD
Ropinirole—Abdominal pain upper—Varenicline—nicotine dependence	0.000758	0.0033	CcSEcCtD
Ropinirole—Hypokalaemia—Varenicline—nicotine dependence	0.000756	0.00329	CcSEcCtD
Ropinirole—Breast disorder—Varenicline—nicotine dependence	0.00075	0.00326	CcSEcCtD
Ropinirole—Cramp muscle—Varenicline—nicotine dependence	0.000748	0.00325	CcSEcCtD
Ropinirole—Nasopharyngitis—Varenicline—nicotine dependence	0.000742	0.00323	CcSEcCtD
Ropinirole—Gastritis—Varenicline—nicotine dependence	0.000735	0.0032	CcSEcCtD
Ropinirole—HTR1B—brain—nicotine dependence	0.000732	0.0286	CbGeAlD
Ropinirole—Abdominal distension—Varenicline—nicotine dependence	0.000722	0.00314	CcSEcCtD
Ropinirole—Dysphagia—Varenicline—nicotine dependence	0.000718	0.00312	CcSEcCtD
Ropinirole—Asthma—Varenicline—nicotine dependence	0.000718	0.00312	CcSEcCtD
Ropinirole—HTR2A—cardiovascular system—nicotine dependence	0.000717	0.0281	CbGeAlD
Ropinirole—HTR1D—brain—nicotine dependence	0.000708	0.0277	CbGeAlD
Ropinirole—HTR2C—brain—nicotine dependence	0.000702	0.0275	CbGeAlD
Ropinirole—Angina pectoris—Varenicline—nicotine dependence	0.000699	0.00304	CcSEcCtD
Ropinirole—Bronchitis—Varenicline—nicotine dependence	0.00069	0.003	CcSEcCtD
Ropinirole—Abdominal discomfort—Varenicline—nicotine dependence	0.000688	0.00299	CcSEcCtD
Ropinirole—Pollakiuria—Varenicline—nicotine dependence	0.000663	0.00288	CcSEcCtD
Ropinirole—Erectile dysfunction—Varenicline—nicotine dependence	0.000661	0.00287	CcSEcCtD
Ropinirole—HTR2B—brain—nicotine dependence	0.000659	0.0258	CbGeAlD
Ropinirole—ADRA2A—midbrain—nicotine dependence	0.000659	0.0258	CbGeAlD
Ropinirole—Photosensitivity reaction—Varenicline—nicotine dependence	0.000655	0.00285	CcSEcCtD
Ropinirole—Weight increased—Varenicline—nicotine dependence	0.000653	0.00284	CcSEcCtD
Ropinirole—Hyperglycaemia—Varenicline—nicotine dependence	0.000647	0.00282	CcSEcCtD
Ropinirole—Infestation—Varenicline—nicotine dependence	0.00064	0.00278	CcSEcCtD
Ropinirole—Infestation NOS—Varenicline—nicotine dependence	0.00064	0.00278	CcSEcCtD
Ropinirole—Depression—Varenicline—nicotine dependence	0.000638	0.00278	CcSEcCtD
Ropinirole—Acute coronary syndrome—Varenicline—nicotine dependence	0.000631	0.00274	CcSEcCtD
Ropinirole—Myocardial infarction—Varenicline—nicotine dependence	0.000627	0.00273	CcSEcCtD
Ropinirole—Stomatitis—Varenicline—nicotine dependence	0.000624	0.00271	CcSEcCtD
Ropinirole—Conjunctivitis—Varenicline—nicotine dependence	0.000622	0.00271	CcSEcCtD
Ropinirole—Hepatobiliary disease—Varenicline—nicotine dependence	0.000605	0.00263	CcSEcCtD
Ropinirole—Epistaxis—Varenicline—nicotine dependence	0.000603	0.00263	CcSEcCtD
Ropinirole—Sinusitis—Varenicline—nicotine dependence	0.0006	0.00261	CcSEcCtD
Ropinirole—HTR1A—brain—nicotine dependence	0.00059	0.0231	CbGeAlD
Ropinirole—Bradycardia—Varenicline—nicotine dependence	0.000585	0.00254	CcSEcCtD
Ropinirole—Hypoaesthesia—Varenicline—nicotine dependence	0.000571	0.00249	CcSEcCtD
Ropinirole—Hallucination—Varenicline—nicotine dependence	0.000571	0.00249	CcSEcCtD
Ropinirole—Urinary tract disorder—Varenicline—nicotine dependence	0.000567	0.00247	CcSEcCtD
Ropinirole—Oedema peripheral—Varenicline—nicotine dependence	0.000566	0.00246	CcSEcCtD
Ropinirole—Connective tissue disorder—Varenicline—nicotine dependence	0.000564	0.00246	CcSEcCtD
Ropinirole—Urethral disorder—Varenicline—nicotine dependence	0.000563	0.00245	CcSEcCtD
Ropinirole—HTR2A—midbrain—nicotine dependence	0.00056	0.0219	CbGeAlD
Ropinirole—Visual impairment—Varenicline—nicotine dependence	0.000553	0.00241	CcSEcCtD
Ropinirole—Eye disorder—Varenicline—nicotine dependence	0.000537	0.00233	CcSEcCtD
Ropinirole—Tinnitus—Varenicline—nicotine dependence	0.000535	0.00233	CcSEcCtD
Ropinirole—DRD2—brain—nicotine dependence	0.000534	0.0209	CbGeAlD
Ropinirole—Cardiac disorder—Varenicline—nicotine dependence	0.000533	0.00232	CcSEcCtD
Ropinirole—Angiopathy—Varenicline—nicotine dependence	0.000521	0.00227	CcSEcCtD
Ropinirole—Immune system disorder—Varenicline—nicotine dependence	0.000519	0.00226	CcSEcCtD
Ropinirole—ADRA2C—brain—nicotine dependence	0.000519	0.0203	CbGeAlD
Ropinirole—Mediastinal disorder—Varenicline—nicotine dependence	0.000518	0.00225	CcSEcCtD
Ropinirole—Chills—Varenicline—nicotine dependence	0.000515	0.00224	CcSEcCtD
Ropinirole—Arrhythmia—Varenicline—nicotine dependence	0.000513	0.00223	CcSEcCtD
Ropinirole—Mental disorder—Varenicline—nicotine dependence	0.000503	0.00219	CcSEcCtD
Ropinirole—Malnutrition—Varenicline—nicotine dependence	0.0005	0.00217	CcSEcCtD
Ropinirole—Flatulence—Varenicline—nicotine dependence	0.000493	0.00214	CcSEcCtD
Ropinirole—Dysgeusia—Varenicline—nicotine dependence	0.00049	0.00213	CcSEcCtD
Ropinirole—Back pain—Varenicline—nicotine dependence	0.000484	0.0021	CcSEcCtD
Ropinirole—Muscle spasms—Varenicline—nicotine dependence	0.000481	0.00209	CcSEcCtD
Ropinirole—Vision blurred—Varenicline—nicotine dependence	0.000471	0.00205	CcSEcCtD
Ropinirole—Tremor—Varenicline—nicotine dependence	0.000468	0.00204	CcSEcCtD
Ropinirole—Ill-defined disorder—Varenicline—nicotine dependence	0.000464	0.00202	CcSEcCtD
Ropinirole—Anaemia—Varenicline—nicotine dependence	0.000462	0.00201	CcSEcCtD
Ropinirole—Agitation—Varenicline—nicotine dependence	0.000459	0.002	CcSEcCtD
Ropinirole—Angioedema—Varenicline—nicotine dependence	0.000457	0.00199	CcSEcCtD
Ropinirole—Malaise—Varenicline—nicotine dependence	0.000451	0.00196	CcSEcCtD
Ropinirole—Vertigo—Varenicline—nicotine dependence	0.000449	0.00195	CcSEcCtD
Ropinirole—Syncope—Varenicline—nicotine dependence	0.000448	0.00195	CcSEcCtD
Ropinirole—Palpitations—Varenicline—nicotine dependence	0.000442	0.00192	CcSEcCtD
Ropinirole—Loss of consciousness—Varenicline—nicotine dependence	0.000439	0.00191	CcSEcCtD
Ropinirole—Cough—Varenicline—nicotine dependence	0.000436	0.0019	CcSEcCtD
Ropinirole—Convulsion—Varenicline—nicotine dependence	0.000433	0.00188	CcSEcCtD
Ropinirole—Hypertension—Varenicline—nicotine dependence	0.000432	0.00188	CcSEcCtD
Ropinirole—Arthralgia—Varenicline—nicotine dependence	0.000426	0.00185	CcSEcCtD
Ropinirole—Chest pain—Varenicline—nicotine dependence	0.000426	0.00185	CcSEcCtD
Ropinirole—Myalgia—Varenicline—nicotine dependence	0.000426	0.00185	CcSEcCtD
Ropinirole—Anxiety—Varenicline—nicotine dependence	0.000424	0.00185	CcSEcCtD
Ropinirole—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000423	0.00184	CcSEcCtD
Ropinirole—Discomfort—Varenicline—nicotine dependence	0.000421	0.00183	CcSEcCtD
Ropinirole—Dry mouth—Varenicline—nicotine dependence	0.000416	0.00181	CcSEcCtD
Ropinirole—ADRA2A—brain—nicotine dependence	0.000414	0.0162	CbGeAlD
Ropinirole—Oedema—Varenicline—nicotine dependence	0.000408	0.00178	CcSEcCtD
Ropinirole—Infection—Varenicline—nicotine dependence	0.000405	0.00176	CcSEcCtD
Ropinirole—Shock—Varenicline—nicotine dependence	0.000401	0.00175	CcSEcCtD
Ropinirole—Nervous system disorder—Varenicline—nicotine dependence	0.0004	0.00174	CcSEcCtD
Ropinirole—Thrombocytopenia—Varenicline—nicotine dependence	0.0004	0.00174	CcSEcCtD
Ropinirole—Tachycardia—Varenicline—nicotine dependence	0.000398	0.00173	CcSEcCtD
Ropinirole—Skin disorder—Varenicline—nicotine dependence	0.000396	0.00172	CcSEcCtD
Ropinirole—Hyperhidrosis—Varenicline—nicotine dependence	0.000394	0.00172	CcSEcCtD
Ropinirole—Anorexia—Varenicline—nicotine dependence	0.000389	0.00169	CcSEcCtD
Ropinirole—Hypotension—Varenicline—nicotine dependence	0.000381	0.00166	CcSEcCtD
Ropinirole—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000372	0.00162	CcSEcCtD
Ropinirole—Insomnia—Varenicline—nicotine dependence	0.000369	0.00161	CcSEcCtD
Ropinirole—Dyspnoea—Varenicline—nicotine dependence	0.000364	0.00158	CcSEcCtD
Ropinirole—Somnolence—Varenicline—nicotine dependence	0.000363	0.00158	CcSEcCtD
Ropinirole—Dyspepsia—Varenicline—nicotine dependence	0.000359	0.00156	CcSEcCtD
Ropinirole—Decreased appetite—Varenicline—nicotine dependence	0.000355	0.00154	CcSEcCtD
Ropinirole—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000352	0.00153	CcSEcCtD
Ropinirole—HTR2A—brain—nicotine dependence	0.000352	0.0138	CbGeAlD
Ropinirole—Fatigue—Varenicline—nicotine dependence	0.000352	0.00153	CcSEcCtD
Ropinirole—Constipation—Varenicline—nicotine dependence	0.000349	0.00152	CcSEcCtD
Ropinirole—Pain—Varenicline—nicotine dependence	0.000349	0.00152	CcSEcCtD
Ropinirole—Feeling abnormal—Varenicline—nicotine dependence	0.000336	0.00146	CcSEcCtD
Ropinirole—Gastrointestinal pain—Varenicline—nicotine dependence	0.000334	0.00145	CcSEcCtD
Ropinirole—Urticaria—Varenicline—nicotine dependence	0.000324	0.00141	CcSEcCtD
Ropinirole—Abdominal pain—Varenicline—nicotine dependence	0.000323	0.0014	CcSEcCtD
Ropinirole—Body temperature increased—Varenicline—nicotine dependence	0.000323	0.0014	CcSEcCtD
Ropinirole—CYP2D6—brain—nicotine dependence	0.000321	0.0125	CbGeAlD
Ropinirole—Hypersensitivity—Varenicline—nicotine dependence	0.000301	0.00131	CcSEcCtD
Ropinirole—Asthenia—Varenicline—nicotine dependence	0.000293	0.00127	CcSEcCtD
Ropinirole—Pruritus—Varenicline—nicotine dependence	0.000289	0.00126	CcSEcCtD
Ropinirole—Diarrhoea—Varenicline—nicotine dependence	0.000279	0.00121	CcSEcCtD
Ropinirole—Dizziness—Varenicline—nicotine dependence	0.00027	0.00117	CcSEcCtD
Ropinirole—Vomiting—Varenicline—nicotine dependence	0.000259	0.00113	CcSEcCtD
Ropinirole—Rash—Varenicline—nicotine dependence	0.000257	0.00112	CcSEcCtD
Ropinirole—Dermatitis—Varenicline—nicotine dependence	0.000257	0.00112	CcSEcCtD
Ropinirole—Headache—Varenicline—nicotine dependence	0.000256	0.00111	CcSEcCtD
Ropinirole—Nausea—Varenicline—nicotine dependence	0.000242	0.00105	CcSEcCtD
Ropinirole—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000163	0.00126	CbGpPWpGaD
Ropinirole—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000163	0.00126	CbGpPWpGaD
Ropinirole—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000162	0.00125	CbGpPWpGaD
Ropinirole—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000161	0.00124	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000161	0.00124	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000161	0.00124	CbGpPWpGaD
Ropinirole—DRD4—GPCR ligand binding—OPRM1—nicotine dependence	0.000161	0.00124	CbGpPWpGaD
Ropinirole—DRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00016	0.00123	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000159	0.00122	CbGpPWpGaD
Ropinirole—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000158	0.00122	CbGpPWpGaD
Ropinirole—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000158	0.00122	CbGpPWpGaD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000158	0.00122	CbGpPWpGaD
Ropinirole—DRD5—GPCR ligand binding—DRD2—nicotine dependence	0.000157	0.00121	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000157	0.00121	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—TAS2R16—nicotine dependence	0.000156	0.0012	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.000156	0.0012	CbGpPWpGaD
Ropinirole—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000155	0.00119	CbGpPWpGaD
Ropinirole—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000154	0.00118	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—FGD1—nicotine dependence	0.000153	0.00118	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000153	0.00118	CbGpPWpGaD
Ropinirole—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000152	0.00117	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000152	0.00117	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000151	0.00116	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000151	0.00116	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—FGD1—nicotine dependence	0.00015	0.00115	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00015	0.00115	CbGpPWpGaD
Ropinirole—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000148	0.00114	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000146	0.00113	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000146	0.00113	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000146	0.00113	CbGpPWpGaD
Ropinirole—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000146	0.00112	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000145	0.00111	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000144	0.00111	CbGpPWpGaD
Ropinirole—ADRA2C—G alpha (i) signalling events—DRD2—nicotine dependence	0.000144	0.00111	CbGpPWpGaD
Ropinirole—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000143	0.0011	CbGpPWpGaD
Ropinirole—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000143	0.0011	CbGpPWpGaD
Ropinirole—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000143	0.0011	CbGpPWpGaD
Ropinirole—DRD3—GPCR ligand binding—OPRM1—nicotine dependence	0.000143	0.0011	CbGpPWpGaD
Ropinirole—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000141	0.00108	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000138	0.00106	CbGpPWpGaD
Ropinirole—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000138	0.00106	CbGpPWpGaD
Ropinirole—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000137	0.00106	CbGpPWpGaD
Ropinirole—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000137	0.00105	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—FGD1—nicotine dependence	0.000136	0.00105	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.000135	0.00104	CbGpPWpGaD
Ropinirole—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000135	0.00104	CbGpPWpGaD
Ropinirole—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000135	0.00104	CbGpPWpGaD
Ropinirole—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000133	0.00103	CbGpPWpGaD
Ropinirole—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000133	0.00102	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000133	0.00102	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000131	0.00101	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000131	0.00101	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000131	0.00101	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.00013	0.001	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000129	0.000991	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000128	0.000987	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000127	0.000973	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000124	0.000956	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000124	0.000951	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000123	0.000946	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—OPRM1—nicotine dependence	0.000123	0.000946	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—FGD1—nicotine dependence	0.000123	0.000945	CbGpPWpGaD
Ropinirole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000122	0.000941	CbGpPWpGaD
Ropinirole—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.00012	0.000927	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—OPRM1—nicotine dependence	0.00012	0.000925	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.00012	0.000922	CbGpPWpGaD
Ropinirole—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000119	0.000916	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000119	0.000915	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000119	0.000914	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.000118	0.000909	CbGpPWpGaD
Ropinirole—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000118	0.000908	CbGpPWpGaD
Ropinirole—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000118	0.000908	CbGpPWpGaD
Ropinirole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000117	0.000903	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000117	0.000903	CbGpPWpGaD
Ropinirole—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000117	0.000898	CbGpPWpGaD
Ropinirole—DRD4—GPCR ligand binding—DRD2—nicotine dependence	0.000116	0.000893	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—TAS2R16—nicotine dependence	0.000115	0.000888	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—FGD1—nicotine dependence	0.000115	0.000884	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000115	0.000883	CbGpPWpGaD
Ropinirole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000114	0.000879	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000113	0.000869	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—OPRM1—nicotine dependence	0.000112	0.000859	CbGpPWpGaD
Ropinirole—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000111	0.000853	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.00011	0.000848	CbGpPWpGaD
Ropinirole—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000109	0.00084	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—AKR1B10—nicotine dependence	0.000108	0.000834	CbGpPWpGaD
Ropinirole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000108	0.000833	CbGpPWpGaD
Ropinirole—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000107	0.000826	CbGpPWpGaD
Ropinirole—DRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000105	0.000804	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000104	0.000802	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000104	0.0008	CbGpPWpGaD
Ropinirole—DRD3—GPCR ligand binding—DRD2—nicotine dependence	0.000103	0.000793	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000103	0.000791	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000103	0.000789	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—TAS2R16—nicotine dependence	0.000103	0.000789	CbGpPWpGaD
Ropinirole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000102	0.000784	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	9.77e-05	0.000752	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	9.42e-05	0.000725	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—FGD1—nicotine dependence	9.4e-05	0.000724	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	9.33e-05	0.000718	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	9.31e-05	0.000716	CbGpPWpGaD
Ropinirole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	9.28e-05	0.000714	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	9.26e-05	0.000712	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	9.22e-05	0.000709	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—FGD1—nicotine dependence	9.21e-05	0.000708	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—OPRM1—nicotine dependence	9.07e-05	0.000698	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—FGD1—nicotine dependence	9.06e-05	0.000697	CbGpPWpGaD
Ropinirole—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	8.99e-05	0.000691	CbGpPWpGaD
Ropinirole—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	8.94e-05	0.000688	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	8.94e-05	0.000688	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	8.89e-05	0.000684	CbGpPWpGaD
Ropinirole—DRD5—GPCR downstream signaling—DRD2—nicotine dependence	8.89e-05	0.000684	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR ligand binding—DRD2—nicotine dependence	8.7e-05	0.000669	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	8.66e-05	0.000666	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—TAS2R16—nicotine dependence	8.65e-05	0.000665	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—FGD1—nicotine dependence	8.65e-05	0.000665	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	8.55e-05	0.000658	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	8.37e-05	0.000644	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	8.31e-05	0.000639	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—OPRM1—nicotine dependence	8.24e-05	0.000634	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—OPRM1—nicotine dependence	8.17e-05	0.000628	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—FGD1—nicotine dependence	8.16e-05	0.000628	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	8.13e-05	0.000626	CbGpPWpGaD
Ropinirole—DRD5—Signaling by GPCR—DRD2—nicotine dependence	8.07e-05	0.000621	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—OPRM1—nicotine dependence	8.06e-05	0.00062	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—FGD1—nicotine dependence	8.05e-05	0.000619	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—AKR1B10—nicotine dependence	8e-05	0.000616	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	7.87e-05	0.000605	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	7.85e-05	0.000604	CbGpPWpGaD
Ropinirole—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	7.76e-05	0.000597	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	7.72e-05	0.000594	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—WASF2—nicotine dependence	7.64e-05	0.000588	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	7.64e-05	0.000588	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—OPRM1—nicotine dependence	7.42e-05	0.000571	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—WASF1—nicotine dependence	7.33e-05	0.000564	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—OPRM1—nicotine dependence	7.32e-05	0.000563	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	7.28e-05	0.00056	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	7.27e-05	0.000559	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—AKR1B10—nicotine dependence	7.21e-05	0.000554	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—AKR1B10—nicotine dependence	7.11e-05	0.000547	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	7.06e-05	0.000543	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	7.03e-05	0.000541	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	7.02e-05	0.00054	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—FGD1—nicotine dependence	7.01e-05	0.00054	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.99e-05	0.000538	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—FGD1—nicotine dependence	6.98e-05	0.000537	CbGpPWpGaD
Ropinirole—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	6.81e-05	0.000524	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—OPRM1—nicotine dependence	6.8e-05	0.000523	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—FGD1—nicotine dependence	6.79e-05	0.000522	CbGpPWpGaD
Ropinirole—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	6.67e-05	0.000513	CbGpPWpGaD
Ropinirole—ADRA2C—Metabolism—CYP2A7—nicotine dependence	6.67e-05	0.000513	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	6.61e-05	0.000508	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—OPRM1—nicotine dependence	6.6e-05	0.000507	CbGpPWpGaD
Ropinirole—DRD4—GPCR downstream signaling—DRD2—nicotine dependence	6.56e-05	0.000505	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	6.42e-05	0.000494	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	6.38e-05	0.000491	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	6.35e-05	0.000488	CbGpPWpGaD
Ropinirole—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	6.26e-05	0.000482	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	6.2e-05	0.000477	CbGpPWpGaD
Ropinirole—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	6.18e-05	0.000476	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—OPRM1—nicotine dependence	6.17e-05	0.000475	CbGpPWpGaD
Ropinirole—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	6.17e-05	0.000475	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	6.16e-05	0.000474	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—FGD1—nicotine dependence	6.16e-05	0.000474	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	6.07e-05	0.000467	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—FGD1—nicotine dependence	6.06e-05	0.000466	CbGpPWpGaD
Ropinirole—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	6.05e-05	0.000466	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—AKR1B10—nicotine dependence	6e-05	0.000461	CbGpPWpGaD
Ropinirole—DRD4—Signaling by GPCR—DRD2—nicotine dependence	5.96e-05	0.000458	CbGpPWpGaD
Ropinirole—DRD1—GPCR downstream signaling—DRD2—nicotine dependence	5.91e-05	0.000454	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—WASF2—nicotine dependence	5.85e-05	0.00045	CbGpPWpGaD
Ropinirole—DRD3—GPCR downstream signaling—DRD2—nicotine dependence	5.83e-05	0.000448	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—WASF2—nicotine dependence	5.73e-05	0.000441	CbGpPWpGaD
Ropinirole—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	5.69e-05	0.000438	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—WASF2—nicotine dependence	5.64e-05	0.000434	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—WASF1—nicotine dependence	5.61e-05	0.000432	CbGpPWpGaD
Ropinirole—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	5.6e-05	0.000431	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	5.52e-05	0.000425	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	5.51e-05	0.000424	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	5.51e-05	0.000424	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—WASF1—nicotine dependence	5.49e-05	0.000423	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	5.44e-05	0.000419	CbGpPWpGaD
Ropinirole—ADRA2A—Metabolism—CYP2A7—nicotine dependence	5.41e-05	0.000417	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—WASF1—nicotine dependence	5.41e-05	0.000416	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—WASF2—nicotine dependence	5.38e-05	0.000414	CbGpPWpGaD
Ropinirole—DRD1—Signaling by GPCR—DRD2—nicotine dependence	5.36e-05	0.000413	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	5.35e-05	0.000412	CbGpPWpGaD
Ropinirole—DRD3—Signaling by GPCR—DRD2—nicotine dependence	5.29e-05	0.000407	CbGpPWpGaD
Ropinirole—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	5.26e-05	0.000405	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—WASF1—nicotine dependence	5.16e-05	0.000397	CbGpPWpGaD
Ropinirole—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	5.08e-05	0.000391	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—WASF2—nicotine dependence	5.08e-05	0.000391	CbGpPWpGaD
Ropinirole—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	5.05e-05	0.000389	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	5.05e-05	0.000389	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	5.01e-05	0.000386	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—WASF2—nicotine dependence	5.01e-05	0.000385	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	4.95e-05	0.000381	CbGpPWpGaD
Ropinirole—ADRA2C—GPCR downstream signaling—DRD2—nicotine dependence	4.91e-05	0.000378	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	4.87e-05	0.000375	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—OPRM1—nicotine dependence	4.87e-05	0.000375	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—WASF1—nicotine dependence	4.87e-05	0.000374	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—WASF1—nicotine dependence	4.8e-05	0.000369	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	4.78e-05	0.000368	CbGpPWpGaD
Ropinirole—DRD5—Signaling Pathways—DRD2—nicotine dependence	4.77e-05	0.000367	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	4.65e-05	0.000358	CbGpPWpGaD
Ropinirole—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	4.61e-05	0.000355	CbGpPWpGaD
Ropinirole—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	4.59e-05	0.000353	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	4.52e-05	0.000348	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling by GPCR—DRD2—nicotine dependence	4.46e-05	0.000343	CbGpPWpGaD
Ropinirole—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	4.39e-05	0.000338	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—OPRM1—nicotine dependence	4.38e-05	0.000337	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—WASF2—nicotine dependence	4.37e-05	0.000336	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—WASF2—nicotine dependence	4.34e-05	0.000334	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	4.34e-05	0.000334	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—OPRM1—nicotine dependence	4.32e-05	0.000333	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—WASF2—nicotine dependence	4.22e-05	0.000325	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—WASF1—nicotine dependence	4.19e-05	0.000322	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—WASF1—nicotine dependence	4.16e-05	0.00032	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—WASF1—nicotine dependence	4.05e-05	0.000312	CbGpPWpGaD
Ropinirole—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	3.99e-05	0.000307	CbGpPWpGaD
Ropinirole—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	3.98e-05	0.000307	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	3.9e-05	0.0003	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—WASF2—nicotine dependence	3.83e-05	0.000295	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—WASF2—nicotine dependence	3.77e-05	0.00029	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	3.77e-05	0.00029	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	3.75e-05	0.000288	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—WASF1—nicotine dependence	3.67e-05	0.000283	CbGpPWpGaD
Ropinirole—HTR1D—Signaling Pathways—DRD2—nicotine dependence	3.65e-05	0.000281	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—OPRM1—nicotine dependence	3.65e-05	0.000281	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	3.62e-05	0.000279	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—WASF1—nicotine dependence	3.62e-05	0.000278	CbGpPWpGaD
Ropinirole—HTR1B—Signaling Pathways—DRD2—nicotine dependence	3.58e-05	0.000275	CbGpPWpGaD
Ropinirole—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.53e-05	0.000271	CbGpPWpGaD
Ropinirole—DRD4—Signaling Pathways—DRD2—nicotine dependence	3.52e-05	0.000271	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	3.43e-05	0.000264	CbGpPWpGaD
Ropinirole—HTR2B—Signaling Pathways—DRD2—nicotine dependence	3.36e-05	0.000258	CbGpPWpGaD
Ropinirole—DRD2—Signaling Pathways—OPRM1—nicotine dependence	3.31e-05	0.000255	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	3.29e-05	0.000253	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	3.26e-05	0.00025	CbGpPWpGaD
Ropinirole—DRD1—Signaling Pathways—DRD2—nicotine dependence	3.17e-05	0.000244	CbGpPWpGaD
Ropinirole—DRD3—Signaling Pathways—DRD2—nicotine dependence	3.13e-05	0.000241	CbGpPWpGaD
Ropinirole—CYP1A2—Metabolism—CYP2A7—nicotine dependence	2.99e-05	0.00023	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	2.96e-05	0.000228	CbGpPWpGaD
Ropinirole—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	2.82e-05	0.000217	CbGpPWpGaD
Ropinirole—HTR1A—Signaling Pathways—DRD2—nicotine dependence	2.72e-05	0.00021	CbGpPWpGaD
Ropinirole—HTR2C—Signaling Pathways—DRD2—nicotine dependence	2.71e-05	0.000209	CbGpPWpGaD
Ropinirole—ADRA2C—Signaling Pathways—DRD2—nicotine dependence	2.64e-05	0.000203	CbGpPWpGaD
Ropinirole—HTR2A—Signaling Pathways—DRD2—nicotine dependence	2.35e-05	0.000181	CbGpPWpGaD
Ropinirole—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.31e-05	0.000177	CbGpPWpGaD
Ropinirole—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	2.14e-05	0.000165	CbGpPWpGaD
